Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Burkitt Lymphoma 9Vomiting 5Nausea 5Lymphoma, Mantle-Cell 4Hodgkin Disease 4Breast Neoplasms 4Neoplasms, Plasma Cell 3Lymphoma, Non-Hodgkin 3Leukemia, Biphenotypic, Acute 3Immunoglobulin Light-chain Amyloidosis 3Sarcoma 2Recurrence 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neuroblastoma 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Hairy Cell 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1

Interventions

Cyclophosphamide 44Peripheral Blood Stem Cell Transplantation 25fludarabine phosphate 24Doxorubicin 23Etoposide 22Vincristine 21Prednisone 20Whole-Body Irradiation 19Rituximab 18Filgrastim 16Brentuximab Vedotin 15Mycophenolic Acid 14Cyclosporine 14Busulfan 14Methotrexate 12Radiotherapy 11Cytarabine 11Carboplatin 10Melphalan 9Ifosfamide 9Antilymphocyte Serum 9Tacrolimus 8Methylprednisolone 8Gemcitabine 8Bortezomib 8Dexamethasone 7Vorinostat 6Everolimus 6Crizotinib 6romidepsin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, Large-Cell, Anaplastic × dexamethasone acetate × Clear all
NCT01979536 2024-04-30

Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
137 enrolled 13 charts
Lymphoid

Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡